Lancet Gastroenterology & Hepatology
Scope & Guideline
Illuminating breakthroughs in gastroenterology and hepatology.
Introduction
Aims and Scopes
- Clinical Research and Trials:
The journal publishes original research on clinical trials related to gastrointestinal diseases, liver disorders, and treatment strategies, highlighting advancements in therapeutic approaches. - Public Health and Epidemiology:
It addresses global health issues related to gastroenterology and hepatology, including the epidemiology of liver diseases and the impact of public health policies on disease management. - Technological Innovations in Gastroenterology:
The journal explores the integration of technology in clinical practice, such as artificial intelligence in endoscopy, which enhances diagnostic accuracy and patient outcomes. - Multidisciplinary Approaches:
It emphasizes collaborative approaches in managing complex conditions like inflammatory bowel disease, liver diseases, and colorectal cancers, promoting integrated care models. - Health Equity and Access:
The journal highlights disparities in healthcare access and outcomes, advocating for equitable treatment options for diverse populations affected by gastrointestinal and liver disorders.
Trending and Emerging
- Artificial Intelligence and Machine Learning:
There is a significant uptick in studies exploring the application of AI and machine learning in diagnostics and treatment planning, particularly in endoscopy and personalized medicine. - Microbiome Research:
A growing body of work is focusing on the role of the gut microbiome in gastrointestinal health and disease, with implications for treatment strategies and dietary interventions. - Integrated Care Models:
Emerging themes emphasize integrated care approaches for chronic conditions like inflammatory bowel disease and liver diseases, promoting collaboration across specialties for better patient outcomes. - Health Disparities and Equity:
An increasing number of studies are addressing health disparities and advocating for equity in healthcare access and treatment, particularly in underserved populations. - Innovative Treatment Modalities:
Research is trending towards novel treatment modalities, including biologics and advanced therapeutics for conditions like non-alcoholic fatty liver disease and inflammatory bowel disease, reflecting a shift in therapeutic focus.
Declining or Waning
- Traditional Pharmacotherapy:
There is a noticeable decline in publications focused solely on traditional pharmacotherapy for gastrointestinal disorders, as the field shifts towards precision medicine and personalized therapies. - Invasive Diagnostic Procedures:
Research related to invasive diagnostic procedures has decreased, with a growing preference for non-invasive techniques and advanced imaging technologies. - Single-Disease Focus:
The emphasis on single-disease studies is waning, as there is an increasing trend towards holistic and multidisciplinary approaches to patient care, encompassing comorbidities and overall health. - Static Treatment Protocols:
There is a reduction in studies advocating for static treatment protocols, with a shift towards adaptive treatment strategies that consider individual patient responses and preferences. - Basic Science Research:
While still relevant, basic science research in gastroenterology and hepatology is receiving less emphasis compared to clinical and translational research, reflecting a prioritization of immediate clinical applications.
Similar Journals
Gastroenterology
Leading the Way in Gastrointestinal Research ExcellenceGastroenterology, published by W B Saunders Co-Elsevier Inc, is a premier journal dedicated to advancing the knowledge and practice within the fields of gastroenterology and hepatology. Established in 1945 and covering a wide range of topics related to digestive health, this journal holds a distinguished position in the academic community, as evidenced by its impressive Q1 status in both Gastroenterology and Hepatology categories, and its high rankings (4th in both disciplines) in Scopus, placing it in the top percentile for scholarly impact. With its commitment to publishing high-quality research, reviews, and clinical studies, Gastroenterology provides an essential resource for researchers, healthcare professionals, and students seeking cutting-edge insights that inform clinical practices and enhance patient care. Although it does not currently offer open access, the journal continues to serve as a vital platform for disseminating meaningful research that shapes the future of digestive disease management.
United European Gastroenterology Journal
Fostering collaboration in cutting-edge medical research.The United European Gastroenterology Journal, published by John Wiley & Sons Ltd, is a leading publication in the fields of gastroenterology and oncology, boasting a distinguished Q1 ranking in both categories for 2023. With an ISSN of 2050-6406 and an E-ISSN of 2050-6414, this journal serves as a vital platform for disseminating cutting-edge research and innovative practices from 2013 to 2024, supporting the advancement of knowledge in gastrointestinal health and cancer treatment. With a commendable Scopus Rank of 14th out of 167 in gastroenterology and 54th out of 404 in oncology, it emphasizes the significance of impactful research in these critical areas. While currently not an open-access journal, it remains a vital resource for researchers, professionals, and students seeking comprehensive insights and evidence-based approaches to improve patient care and clinical outcomes. The United European Gastroenterology Journal is committed to bridging the gap between research and practice, making it an essential reference for those dedicated to the fields of gastroenterology and oncology.
GE Portuguese Journal of Gastroenterology
Pioneering Open Access Research in GastroenterologyThe GE Portuguese Journal of Gastroenterology, published by KARGER, is a prominent platform in the field of gastroenterology, providing a vital forum for the dissemination of high-quality research since its establishment. With an open access model implemented in 2012, the journal ensures that emerging findings in gastrointestinal health are readily accessible to a global audience, facilitating the exchange of critical knowledge among researchers, practitioners, and students alike. Based in Switzerland, this journal has earned a respected position within the academic community, currently holding a Q3 ranking in the gastroenterology category for 2023, alongside a Scopus rank of #113 out of 167 in its field. Spanning converged years from 2014 to 2024, the GE Portuguese Journal of Gastroenterology aims to bridge gaps in research and practice, fostering collaboration and innovation across diverse areas within the discipline. Authors and readers alike benefit from the journal's commitment to advancing knowledge and practice in gastroenterology.
Gastrointestinal Disorders
Unlocking Knowledge in Gastrointestinal Disorders for AllGastrointestinal Disorders is a prominent open-access journal published by MDPI, based in Switzerland, that focuses on the latest research and innovations in the fields of gastroenterology, hepatology, and immunology. Since its inception in 2019, the journal has provided a vital platform for researchers and professionals to disseminate their findings, engaging with a global audience keen on advancing knowledge in gastrointestinal health. With a dedicated commitment to high-quality, peer-reviewed articles, Gastrointestinal Disorders has gained recognition in 2023, achieving Q3 status in gastroenterology and notable rankings in several other categories, including a respectable position in the quartiles for hepatology, immunology, and oncology. Despite its recent establishment, the journal has quickly become a valuable resource, facilitating open access to critical insights in the study of gastrointestinal diseases and their management, ensuring that emerging research is readily available to inform clinical practice and educate future professionals.
DIGESTIVE DISEASES
Connecting Research with Clinical Practice in Gastroenterology.DIGESTIVE DISEASES, published by KARGER, stands as a leading international journal dedicated to the field of gastroenterology and digestive health. With an ISSN of 0257-2753 and E-ISSN 1421-9875, the journal has been providing a platform for high-quality research since its inception in 1983, continuing to disseminate groundbreaking findings and insights through to 2024. Positioned in the second quartile (Q2) of both the gastroenterology and miscellaneous medicine categories as of 2023, DIGESTIVE DISEASES is recognized for its rigorous peer-review process and its contributions to advancing clinical and experimental gastroenterological knowledge. Its Scopus ranking at #62 out of 167 in the gastroenterology field reflects its significant impact, as it reaches a notable 63rd percentile among its peers. While it does not currently offer open access options, its subscription model ensures that vital research is available to professionals and institutions committed to the field. The journal serves as an essential resource for researchers, clinicians, and students alike who seek to deepen their understanding of digestive disorders and their implications in medicine.
Gastroenterology Research and Practice
Advancing Digestive Health Through Innovative ResearchGastroenterology Research and Practice is a leading Open Access journal dedicated to advancing the field of gastroenterology and hepatology. Published by HINDAWI LTD, this journal offers a platform for researchers, clinicians, and healthcare professionals to share their findings and insights on cutting-edge topics in digestive health. With an ISSN of 1687-6121 and an E-ISSN of 1687-630X, it has established its significance within the academic community, evidenced by its ranking in the 2023 Scopus metrics, where it is positioned in the third quartile for both gastroenterology and hepatology disciplines. The journal is recognized for disseminating high-quality, peer-reviewed articles that contribute to the understanding of gastrointestinal disorders, therapeutic advancements, and innovative practices. Since its inception as an Open Access journal in 2008, Gastroenterology Research and Practice has removed barriers to access, ensuring that vital research reaches a global audience. This ongoing commitment to increasing accessibility, alongside its continuous publication from 2009 to 2024, underscores its importance as a resource for the academic and clinical communities striving to improve patient outcomes in digestive diseases.
Best Practice & Research Clinical Gastroenterology
Exploring Innovations in Clinical GastroenterologyBest Practice & Research Clinical Gastroenterology is a leading journal in the field of gastroenterology, published by Elsevier Science Ltd, that aims to disseminate high-quality research and evidence-based guidelines for clinical practice. With an impressive impact factor and ranked in the top tier (Q1) of gastroenterology journals as per Scopus, it is recognized for its critical role in advancing knowledge and best practices in clinical settings. The journal is published biannually with content that spans a wide array of topics affecting the gastrointestinal tract, and it encourages contributions from researchers and professionals who seek to enhance their understanding and improve patient care. It's accessible in both subscription and open access formats, allowing for a broad audience engagement and dissemination of pivotal research findings. Since its inception in 1999, Best Practice & Research Clinical Gastroenterology has served as a vital resource for clinicians and academics alike, contributing significantly to improvements in gastroenterological health.
Canadian Journal of Gastroenterology and Hepatology
Empowering Healthcare through Open Access ResearchCanadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.
Frontline Gastroenterology
Elevating Knowledge in Gastroenterology and HepatologyFrontline Gastroenterology is a leading academic journal published by the BMJ Publishing Group that plays a vital role in advancing the field of gastroenterology and hepatology. Established in 2013, this prestigious journal has established itself as a significant resource for researchers, healthcare professionals, and students alike, maintaining a commendable impact factor and consistently achieving a Q2 ranking in both gastroenterology and hepatology categories as of 2023. With its focus on disseminating high-quality, peer-reviewed research, Frontline Gastroenterology covers a wide scope of topics pertinent to the understanding, diagnosis, and treatment of gastrointestinal and liver diseases. Although it does not offer Open Access options, its content is accessible through various institutional and personal subscriptions, ensuring that critical findings reach an international audience. As the journal continues to converge into the future, it remains dedicated to fostering innovation and dialogue in gastroenterological sciences.
WORLD JOURNAL OF GASTROENTEROLOGY
Empowering the global gastroenterology community.WORLD JOURNAL OF GASTROENTEROLOGY, published by BAISHIDENG PUBLISHING GROUP INC, stands at the forefront of gastrointestinal research, providing a critical platform for the dissemination of high-quality studies in the field. With an impressive impact factor reflected in its Q1 rankings in both Gastroenterology and Miscellaneous Medicine, this journal is recognized for its rigorous peer-review process and commitment to advancing knowledge and practices related to digestive health. Covering comprehensive scopes from clinical advancements to innovative therapies, the journal serves an essential role for researchers, clinicians, and students, enabling them to stay updated on the latest developments and findings from 1998 through 2024. The open access model facilitates broader accessibility, ensuring that groundbreaking research reaches a global audience. The journal's ranking within the top 15% of Scopus demonstrates its significant contribution to the academic community, making it a valuable resource for advancing the science of gastroenterology.